The effect of combined vaginal misoprostol and tourniquet or tourniquet alone on reducing blood loss during abdominal myomectomy

INTERVENTION: pericervical tourniquet vaginal misoprostol plus pericervicl tourniquet CONDITION: ; Primary haemorrhage during myomectomy Primary haemorrhage during myomectomy PRIMARY OUTCOME: To determine the reduction in blood loss using pre‐operative and post‐operative hemoglobin changes between women in the treatment and control groups SECONDARY OUTCOME: To determine the need for intraoperative or post‐operative blood transfusion for women in both the treatment and the control groups. To assess the prevalence of adverse effects of misoprostol in the treatment group. To assess the differences in post‐operative febrile morbidity, surgery duration and length of hospital stay in both the treatment and control groups INCLUSION CRITERIA: All reproductive‐aged women with symptomatic fibroids who desire future fertility Uterine size not exceeding 28 weeks gestation on abdominal examination All women with symptomatic uterine fibroids who give voluntary consent tp partake in the study